Treating type 2 diabetes with SGLT-2 inhibitors

NICE Talks by NICE Talks

Aug 29, 202500:10:39Science & Medicine

In this episode, we discuss recent analysis showing significant disparities in SGLT-2 inhibitor prescriptions for people with type 2 diabetes in England. We also explore how our new draft recommendations for these medica...

Related Episodes

Continue listening to more episodes from NICE Talks.

How NICE prepares for the healthcare of tomorrow

Sep 30, 2026 - 00:12:27

In this episode, we explore the research taking place behind the scenes at NICE and how it helps us prepa...

Second Chances: How new technology is transforming organ transplants

Aug 25, 2026 - 00:13:25

In this episode, we explore how new machine perfusion technology is changing the landscape of organ trans...

PMOS: how the new draft NICE guideline could transform diagnosis and care

Jul 29, 2026 - 00:13:16

In this episode we explore the draft NICE guideline for PMOS (formerly known as PCOS), out for public con...

Changing the course: the NHS's first treatment to delay type 1 diabetes

Jun 30, 2026 - 00:10:40

NICE has recommended teplizumab for NHS use — the first treatment to delay the onset of symptomatic type...

Treating babies at home with oral antibiotics

May 27, 2026 - 00:13:50

In this episode we discuss the recent changes to the NICE guideline for neonatal infections, that mean ne...

Endometriosis fertility care and gynaecological cancer guidance

Apr 29, 2026 - 00:14:51

In this episode of NICE Talks, we're covering some of the most significant guidance updates of the year s...

Backing the healthtech that changes lives

Mar 31, 2026 - 00:13:00

When the right technology reaches the right patient, lives change. In this episode of NICE Talks, we hear...

How NICE guidance is accelerating access to innovative migraine treatments

Feb 26, 2026 - 00:08:13

In this episode, we discuss two innovative migraine treatments recommended by NICE. We explore the rapid...